SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-006432
Filing Date
2019-07-29
Accepted
2019-07-29 08:27:07
Documents
60
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q qure-20190630x10q.htm   iXBRL 10-Q 1842062
2 EX-10.42 qure-20190630ex1042983bf.htm EX-10.42 80301
3 EX-10.43 qure-20190630ex10430d1fb.htm EX-10.43 45643
4 EX-31.1 qure-20190630ex3117e31e4.htm EX-31.1 18173
5 EX-31.2 qure-20190630ex31293587c.htm EX-31.2 18075
6 EX-32.1 qure-20190630ex32181fa52.htm EX-32.1 11148
  Complete submission text file 0001558370-19-006432.txt   8200676

Data Files

Seq Description Document Type Size
7 EX-101.SCH qure-20190630.xsd EX-101.SCH 74763
8 EX-101.CAL qure-20190630_cal.xml EX-101.CAL 62519
9 EX-101.DEF qure-20190630_def.xml EX-101.DEF 465130
10 EX-101.LAB qure-20190630_lab.xml EX-101.LAB 716085
11 EX-101.PRE qure-20190630_pre.xml EX-101.PRE 576943
12 EXTRACTED XBRL INSTANCE DOCUMENT qure-20190630x10q_htm.xml XML 1264826
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-36294 | Film No.: 19979419
SIC: 2834 Pharmaceutical Preparations